June 24, 2026
Ollin Biosciences
Ollin Biosciences is an Austin, Texas-based ophthalmology biotech developing treatments.
- Round
- Series B
- Amount raised
- $330M
- Lead investor
- TCGX
- Industry
- Biotechnology
- Headquarters
- Austin, United States
- Employees
- 11-50 employees
- Website
- ollin.bio
- View profile →
Other investors
- Arch Venture Partners
- a16z
- Blackstone
- Commodore Capital
- RA Capital Management
- CPPIB
Source: Axios Pro Rata